Seqirus Announces FDA Approval of Its First-Ever Adjuvanted, Cell-Based Pandemic Influenza A (H5N1) Vaccine Read more
Geneyork Pharmaceutical Announces U.S. Launch of Generic Version of Deltasone (Prednisone) Tablets Read more